162 related articles for article (PubMed ID: 27176937)
1. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
[TBL] [Abstract][Full Text] [Related]
2. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
3. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
4. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.
St Hill CA; Farooqui M; Mitcheltree G; Gulbahce HE; Jessurun J; Cao Q; Walcheck B
BMC Cancer; 2009 Mar; 9():79. PubMed ID: 19267921
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
6. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
7. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
[TBL] [Abstract][Full Text] [Related]
8. Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?
Sozzani P; Arisio R; Porpiglia M; Benedetto C
Int J Surg Pathol; 2008 Oct; 16(4):365-74. PubMed ID: 18977761
[TBL] [Abstract][Full Text] [Related]
9. A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma.
Taga M; Hoshino H; Low S; Imamura Y; Ito H; Yokoyama O; Kobayashi M
Urol Oncol; 2015 Nov; 33(11):496.e1-9. PubMed ID: 26137907
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Mahauad-Fernandez WD; DeMali KA; Olivier AK; Okeoma CM
Breast Cancer Res; 2014 Dec; 16(6):493. PubMed ID: 25499888
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer.
Ferreira IG; Carrascal M; Mineiro AG; Bugalho A; Borralho P; Silva Z; Dall'olio F; Videira PA
Int J Oncol; 2019 Nov; 55(5):1033-1048. PubMed ID: 31793656
[TBL] [Abstract][Full Text] [Related]
12. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
[TBL] [Abstract][Full Text] [Related]
13. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.
Läubli H; Alisson-Silva F; Stanczak MA; Siddiqui SS; Deng L; Verhagen A; Varki N; Varki A
J Biol Chem; 2014 Nov; 289(48):33481-91. PubMed ID: 25320078
[TBL] [Abstract][Full Text] [Related]
14. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Piccolo E; Tinari N; Semeraro D; Traini S; Fichera I; Cumashi A; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Stampolidis P; Piantelli M; Natoli C; Ullrich A; Iacobelli S
J Mol Med (Berl); 2013 Jan; 91(1):83-94. PubMed ID: 22864925
[TBL] [Abstract][Full Text] [Related]
15. Binding of gastrointestinal tumor cells to endothelial E- and P-selectin adhesion receptors leads to transient down-regulation of sLeX ligands in vitro.
Schuldes H; Schleicher D; Mayer G; Markus BH; Cinatl J; Blaheta RA
Int J Colorectal Dis; 2003 Jul; 18(4):292-9. PubMed ID: 12774243
[TBL] [Abstract][Full Text] [Related]
16. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
[TBL] [Abstract][Full Text] [Related]
17. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma.
Martin TA; Jiang WG
Oncol Rep; 2014 Jan; 31(1):262-72. PubMed ID: 24173498
[TBL] [Abstract][Full Text] [Related]
19. SA-Lea and tumor metastasis: the old prediction and recent findings.
Thurin M; Kieber-Emmons T
Hybrid Hybridomics; 2002 Apr; 21(2):111-6. PubMed ID: 12031100
[TBL] [Abstract][Full Text] [Related]
20. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.
Munro JM; Lo SK; Corless C; Robertson MJ; Lee NC; Barnhill RL; Weinberg DS; Bevilacqua MP
Am J Pathol; 1992 Dec; 141(6):1397-408. PubMed ID: 1281620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
